Oncologists may soon have an accurate and inexpensive way of differentiating between types of ovarian cancer that will improve how patients are treated, thanks to findings from a national research study co-led out of the University of Alberta. The study identified eight biomarkers that will enable pathologists to differentiate between two types of ovarian cancer with 99.2% accuracy.
Source: EurekaAlert, https://www.eurekalert.org